Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 15;12:835559. doi: 10.3389/fonc.2022.835559

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Liu, Sun, Feng, Yang, Chen, Liu, Chai, Mao, Guo, Shi and Cheng

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Kaplan–Meier survival curves of OS and DFS in all HCC patients with BDTT. OS for HCC patients with BDTT in the LR and TACE groups (105 patients vs. 40 patients) before PSM (A) (P < 0.001); DFS in the LR and TACE groups (105 patients vs. 40 patients) before PSM (C) (P < 0.001); OS for HCC patients with BDTT in the LR and TACE groups (53 patients vs. 28 patients) after PSM (B) (P = 0.007); DFS in the LR and TACE groups (53 patients vs. 28 patients) after PSM (D) (P = 0.007). OS, overall survival; DFS, disease-free survival; HCC, hepatocellular carcinoma; BDTT, bile duct tumor thrombus; LR, liver resection; TACE, transcatheter arterial chemoembolization.